BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33127260)

  • 1. Cytokines in the immunity and immunopathogenesis in leishmaniases.
    Saha B; Silvestre R
    Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.
    Soong L; Henard CA; Melby PC
    Semin Immunopathol; 2012 Nov; 34(6):735-51. PubMed ID: 23053396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conundrums in leishmaniasis.
    Saha B; Bhattacharjee S; Sarkar A; Bhor R; Pai K; Bodhale N
    Cytokine; 2021 Sep; 145():155304. PubMed ID: 33004260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.
    Alimohmmadian MH; Ajdary S; Bahrami F
    Iran Biomed J; 2022 Mar; 26(2):99-109. PubMed ID: 35090305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell response in human leishmaniasis.
    Kharazmi A; Kemp K; Ismail A; Gasim S; Gaafar A; Kurtzhals JA; El Hassan AM; Theander TG; Kemp M
    Immunol Lett; 1999 Jan; 65(1-2):105-8. PubMed ID: 10065635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Leishmania with the host macrophage.
    Handman E; Bullen DV
    Trends Parasitol; 2002 Aug; 18(8):332-4. PubMed ID: 12377273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-
    Carneiro MB; Peters NC
    Front Immunol; 2021; 12():728848. PubMed ID: 34557194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and local controls of monocytopoiesis influence the outcome of Leishmania infection.
    Raybarman C; Bhattacharjee S
    Cytokine; 2021 Nov; 147():155325. PubMed ID: 33039254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine saga in visceral leishmaniasis.
    Bhor R; Rafati S; Pai K
    Cytokine; 2021 Nov; 147():155322. PubMed ID: 33127259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permissive and protective roles for neutrophils in leishmaniasis.
    Carlsen ED; Liang Y; Shelite TR; Walker DH; Melby PC; Soong L
    Clin Exp Immunol; 2015 Nov; 182(2):109-18. PubMed ID: 26126690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of infection with the visceralizing Leishmania species.
    Wilson ME; Jeronimo SM; Pearson RD
    Microb Pathog; 2005 Apr; 38(4):147-60. PubMed ID: 15797810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
    Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
    PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
    J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A historical review of the role of cytokines involved in leishmaniasis.
    Mirzaei A; Maleki M; Masoumi E; Maspi N
    Cytokine; 2021 Sep; 145():155297. PubMed ID: 32972825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.
    Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP
    Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.